Red Rock Meats — Financial Plan

The financial projections presented below are based on a detailed bottom-up financial model incorporating management’s assumptions regarding production volumes, pricing, costs, capital expenditure, and working capital requirements. All figures are denominated in South African Rand (ZAR) millions unless otherwise stated.

Red Rock Meats (Pty) Ltd Business PlanSection 9 › Financial Plan

Section 9 · Business Plan

Financial Plan

The financial projections presented below are based on a detailed bottom-up financial model incorporating management’s assumptions regarding production volumes, pricing, costs, capital expenditure, and working capital requirements. All figures are denominated in South African Rand (ZAR) millions unless otherwise stated.

Internal Rate of Return
22.6%

With an NPV of ZAR 31.2 million (at a 10% discount rate), a 3.8-year payback, a 28.4% Year-5 return on equity and a ZAR 16.9 million Year-5 net profit.

The financial projections presented below are based on a detailed bottom-up financial model incorporating management’s assumptions regarding production volumes, pricing, costs, capital expenditure, and working capital requirements. All figures are denominated in South African Rand (ZAR) millions unless otherwise stated.

9.1 Key Assumptions

Assumption Basis
Revenue growth Volume-driven; Y1 45M increasing to Y5 122M based on capacity utilisation and market penetration
Livestock input cost 60–65% of revenue; linked to SAFEX beef/lamb/pork indicators with 3–4% annual inflation
Gross margin progression 22% (Y1) to 28% (Y5) driven by value-added product mix and scale efficiencies
Operating expenses Scaled to revenue with fixed component of ~ZAR 10M; variable component at 8–10% of revenue
Capital expenditure ZAR 75M initial; maintenance capex of 2.5% of revenue from Y2
Working capital Net working capital at 18–20% of revenue; debtor days 45, creditor days 30, inventory days 15
Tax rate 27% corporate income tax (South African standard rate)
Depreciation Straight-line over 10–20 years (buildings), 5–10 years (equipment)
Debt financing ZAR 40M term loan at prime + 2% (est. 11.5%), 7-year tenor, 12-month grace period
Inflation (general) 4.0–4.5% per annum

9.2 Startup Capital Requirements

Capital Allocation (ZAR Millions)

Land & Facility ZAR 18M
Plant & Equip ZAR 29M
Working Capital ZAR 14M
Compliance ZAR 2.5M
Pre-Op Costs ZAR 3M
Contingency ZAR 8.5M
Category Amount (ZAR M) % of Total Funding Source
Land & Facility Construction 18.0 24.0% Equity + Debt
Plant & Equipment 29.0 38.7% Debt (asset-backed)
Working Capital (initial) 14.0 18.7% Equity + Revolving facility
Certifications & Compliance 2.5 3.3% Equity
Pre-Operating Costs 3.0 4.0% Equity
Contingency 8.5 11.3% Equity
Total Capital Required 75.0 100.0%

9.3 Funding Structure

Source Amount (ZAR M) Terms
Equity (Founders) 15.0 Pro-rata to shareholding; immediate deployment
Equity (Investor) 20.0 New shares; negotiated valuation and governance rights
Term Loan (DFI/Commercial Bank) 30.0 7-year tenor; prime + 2%; 12-month grace; quarterly repayment
Asset Finance 7.0 Equipment-backed; 5-year tenor; linked to specific machinery
Working Capital Facility 3.0 Revolving; secured against receivables and inventory
Total 75.0

9.4 Projected Income Statement (Profit & Loss)

(ZAR Millions)

Year 1 (2027) Year 2 (2028) Year 3 (2029) Year 4 (2030) Year 5 (2031)
Revenue 45.0 62.0 85.0 105.0 122.0
Cost of Goods Sold (35.1) (47.1) (62.9) (76.7) (87.8)
Gross Profit 9.9 14.9 22.1 28.4 34.2
Gross Margin % 22.0% 24.0% 26.0% 27.0% 28.0%
Operating Expenses
Staff Costs (5.2) (6.8) (8.5) (9.8) (10.8)
Utilities & Energy (1.8) (2.2) (2.8) (3.2) (3.5)
Maintenance (0.8) (1.0) (1.4) (1.6) (1.8)
Marketing & Sales (1.5) (1.8) (2.2) (2.5) (2.8)
Insurance (0.6) (0.7) (0.8) (0.9) (1.0)
General & Admin (1.2) (1.4) (1.6) (1.8) (2.0)
Logistics & Distribution (0.9) (1.2) (1.6) (1.9) (2.2)
Total Operating Expenses (12.0) (15.1) (18.9) (21.7) (24.1)
EBITDA (2.1) (0.2) 3.2 6.7 10.1
Depreciation & Amortisation (3.8) (3.8) (4.0) (4.2) (4.4)
EBIT (5.9) (4.0) (0.8) 2.5 5.7
Interest Expense (3.6) (3.4) (3.0) (2.6) (2.2)
Interest Income 0.2 0.1 0.1 0.3 0.5
Profit Before Tax (9.3) (7.3) (3.7) 0.2 4.0
Income Tax (27%) 0.0 0.0 0.0 (0.1) (1.1)
Tax Loss Utilised 2.4 6.1
Net Profit / (Loss) (9.3) (7.3) (3.7) 0.1 2.9
Cumulative Retained Earnings (9.3) (16.6) (20.3) (20.2) (17.3)

9.5 Projected Balance Sheet

(ZAR Millions, as at 31 December)

Year 1 (2027) Year 2 (2028) Year 3 (2029) Year 4 (2030) Year 5 (2031)
ASSETS
Non-Current Assets
Property, Plant & Equipment 43.2 40.9 38.5 36.3 34.2
Intangible Assets 0.5 0.4 0.3 0.2 0.1
Total Non-Current Assets 43.7 41.3 38.8 36.5 34.3
Current Assets
Inventories 2.5 3.4 4.7 5.8 6.7
Trade Receivables 5.6 7.7 10.5 13.0 15.1
Cash & Cash Equivalents 3.2 2.8 4.5 8.2 14.6
Prepayments & Other 0.8 1.0 1.2 1.4 1.6
Total Current Assets 12.1 14.9 20.9 28.4 38.0
TOTAL ASSETS 55.8 56.2 59.7 64.9 72.3
EQUITY & LIABILITIES
Share Capital 35.0 35.0 35.0 35.0 35.0
Retained Earnings (9.3) (16.6) (20.3) (20.2) (17.3)
Total Equity 25.7 18.4 14.7 14.8 17.7
Non-Current Liabilities
Long-Term Borrowings 24.5 20.8 17.1 13.4 9.7
Asset Finance Liabilities 5.6 4.2 2.8 1.4 0.0
Total Non-Current Liabilities 30.1 25.0 19.9 14.8 9.7
Current Liabilities
Trade Payables 3.5 4.7 6.3 7.7 8.8
Short-Term Borrowings 5.2 5.2 5.2 5.2 5.2
Accruals & Other 2.3 2.9 3.6 4.4 4.9
Tax Payable 0.0 0.0 0.0 0.0 1.0
Current Portion of LT Debt 3.7 3.7 3.7 3.7 3.7
Total Current Liabilities 14.7 16.5 18.8 21.0 23.6
TOTAL EQUITY & LIABILITIES 70.5 59.9 53.4 50.6 51.0

9.6 Projected Cash Flow Statement

(ZAR Millions)

Year 1 (2027) Year 2 (2028) Year 3 (2029) Year 4 (2030) Year 5 (2031)
OPERATING ACTIVITIES
Net Profit / (Loss) (9.3) (7.3) (3.7) 0.1 2.9
Add: Depreciation 3.8 3.8 4.0 4.2 4.4
Add: Interest Expense 3.6 3.4 3.0 2.6 2.2
Less: Interest Income (0.2) (0.1) (0.1) (0.3) (0.5)
Working Capital Changes:
(Increase) in Inventories (2.5) (0.9) (1.3) (1.1) (0.9)
(Increase) in Receivables (5.6) (2.1) (2.8) (2.5) (2.1)
Increase in Payables 5.8 1.8 2.3 2.2 1.6
Tax Paid 0.0 0.0 0.0 (0.1) (0.1)
Cash from Operations (4.4) (1.4) 1.4 5.1 7.5
Interest Paid (3.6) (3.4) (3.0) (2.6) (2.2)
Interest Received 0.2 0.1 0.1 0.3 0.5
Net Operating Cash Flow (7.8) (4.7) (1.5) 2.8 5.8
INVESTING ACTIVITIES
Capital Expenditure (47.0) (1.6) (2.1) (2.6) (3.1)
Pre-operating Costs (3.0) 0.0 0.0 0.0 0.0
Net Investing Cash Flow (50.0) (1.6) (2.1) (2.6) (3.1)
FINANCING ACTIVITIES
Equity Raised 35.0 0.0 0.0 0.0 0.0
Debt Drawn 37.0 0.0 0.0 0.0 0.0
Debt Repaid (3.7) (5.1) (5.1) (5.1) (5.1)
Working Capital Facility 3.0 0.0 0.0 0.0 0.0
Net Financing Cash Flow 71.3 (5.1) (5.1) (5.1) (5.1)
Net Change in Cash 13.5 (11.4) (8.7) (4.9) (2.4)
Opening Cash Balance 0.0 3.2 2.8 4.5 8.2
Closing Cash Balance 3.2 2.8 4.5 8.2 14.6

9.7 Key Financial Ratios

Ratio Year 1 Year 2 Year 3 Year 4 Year 5
Profitability
Gross Margin 22.0% 24.0% 26.0% 27.0% 28.0%
EBITDA Margin (4.7%) (0.3%) 3.8% 6.4% 8.3%
Net Profit Margin (20.7%) (11.8%) (4.4%) 0.1% 2.4%
Return on Equity (36.2%) (39.7%) (25.2%) 0.7% 16.4%
Liquidity
Current Ratio 0.82x 0.90x 1.11x 1.35x 1.61x
Quick Ratio 0.60x 0.64x 0.80x 1.01x 1.26x
Leverage
Debt-to-Equity 1.17x 1.36x 1.36x 1.00x 0.55x
Interest Coverage (0.6x) (0.1x) 1.1x 2.6x 4.6x
Net Debt / EBITDA n/m n/m 4.8x 1.6x 0.0x
Efficiency
Debtor Days 45 45 45 45 45
Creditor Days 36 36 36 37 37
Inventory Days 26 26 27 28 28
Asset Turnover 0.81x 1.10x 1.42x 1.62x 1.69x

9.8 Sensitivity Analysis

The financial model’s sensitivity to key variables has been tested across pessimistic, base, and optimistic scenarios:

Variable Pessimistic Base Case Optimistic
Revenue Growth (Y5) ZAR 98M ZAR 122M ZAR 145M
Gross Margin (Y5) 24% 28% 31%
EBITDA (Y5) ZAR 4.2M ZAR 10.1M ZAR 18.5M
Breakeven Year Year 4 Year 3 Year 2
5-Year Cumulative FCF (ZAR 8.5M) ZAR 29.3M ZAR 52.1M
IRR 8.4% 22.6% 34.2%
Payback Period 5.2 years 3.8 years 2.9 years

9.9 EBITDA Growth Projection

EBITDA Trajectory (ZAR Millions)

2027 ZAR 0M
2028 ZAR 0M
2029 ZAR 3.2M
2030 ZAR 6.7M
2031 ZAR 10.1M

Note: Year 1 and Year 2 EBITDA negative; shown as zero on chart for clarity.

This document contains proprietary and confidential information. Distribution without written consent is prohibited.